Showing results (2121-2130 of 5,549) with videos related to

Sort By:
Pageof 555
Briefings in Bioinformatics|July 19, 2023
Predicting metabolite-disease associations based on auto-encoder and non-negative matrix factorizationHongyan Gao, Jianqiang Sun, Yukun Wang, et al.
Briefings in Bioinformatics|July 21, 2023
UNMF: a unified nonnegative matrix factorization for multi-dimensional omics dataKo Abe, Teppei Shimamura
Briefings in Bioinformatics|July 10, 2023
ZetaDesign: an end-to-end deep learning method for protein sequence design and side-chain packingJunyu Yan, Shuai Li, Ying Zhang, et al.
Briefings in Bioinformatics|July 5, 2023
Predicting potential microbe-disease associations based on multi-source features and deep learningLiugen Wang, Yan Wang, Chenxu Xuan, et al.
Briefings in Bioinformatics|June 20, 2023
C-RCPred: a multi-objective algorithm for interactive secondary structure prediction of RNA complexes integrating user knowledge and SHAPE dataMandy Ibéné, Audrey Legendre, Guillaume Postic, et al.
Briefings in Bioinformatics|June 9, 2023
Rigorous benchmarking of T-cell receptor repertoire profiling methods for cancer RNA sequencingKerui Peng, Theodore S Nowicki, Katie Campbell, et al.
Briefings in Bioinformatics|February 5, 2019
Evaluation of ontology structural metrics based on public repository dataManuel Franco, Juana María Vivo, Manuel Quesada-Martínez, et al.
Briefings in Bioinformatics|February 6, 2019
Performance of gene expression-based single sample predictors for assessment of clinicopathological subgroups and molecular subtypes in cancers: a case comparison study in non-small cell lung cancerHelena Cirenajwis, Martin Lauss, Maria Planck, et al.
Briefings in Bioinformatics|January 17, 2019
ANPELA: analysis and performance assessment of the label-free quantification workflow for metaproteomic studiesJing Tang, Jianbo Fu, Yunxia Wang, et al.
Briefings in Bioinformatics|January 29, 2019
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugsYing Hong Li, Xiao Xu Li, Jia Jun Hong, et al.
Pageof 555